The rare earth cryptates are used as long-lived fluorescent labels. They are formed by inclusion of a europium ion in the intramolecular cavity of a macropolycyclic ligand containing bipyndine groups as light absorbers. The use of fluoride ions in the measuring medium allows a total shielding of the label fluorescence. Here, I have established the conditions under which the signal of these cryptates can be amplified through the use of nonradiative energy transfer, and applied these conditions to homogeneous immunoassays by using allophycocyanin as the acceptor. Because only a low proportion of the cryptate label is involved in the transfer amplification, and because allophycocyanin emission occurs between the europium emission lines, time-resolved measurement of europium and allophycocyanin emission allows real-time correction of the optical properties of the assay medium. These features have allowed the development of a rapid homogeneous immunoassay of prolactin that can detectas little as 0.3 g/L (3rd International Standard 84/500).
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The development of sensitive homogeneous immunoassays has been the goal of many research teams around the world (1) (2) (3) (4) (5) In practice these requirements are not entirely fulfilled by the known rare earth chelates, particularly in immunoassays. Because of the lack of an "ideal" chelate, these labels are the result of two different approaches in devising analytical ixnmunoassay techniques. In the first approach (18), the Eu3 is used as the label and is carried by the antibody through the immunological re-action by coupled EDTA or diethylenetriaxninepentaacetic acid (DPTA) derivatives. The formation of the highly fluorescent complex is achieved after the immunological reaction by the addition of an excessof a suitable ligand plus a synergistic agent in a detergent solution. This approach has been used successfully but has two limitations: (a) vulnerability to Eu3 contamination (19) , and (b ) nonavailability of the fluorescent signal directly bound to the antibody.
The secondapproach involves the labeling of the immunoreactants by the chelator, the fluorescent complex being formed through the use of an excessof Eu3 (20) . For the commonly known labels, the main limitation of this approach is poor sensitivity of the chelate (21).
The combination of energy absorption, transfer properties of the ligand, and chelate stability in the same molecule are still the objectives of research in this field (22) (23) (24) . This lack of an ideal chelate may explain why rare earth chelate labels have been of little use in homogeneous assays. The highly specific properties of the chelates could help to solve particular problems, such as the background contribution of media (25).
Rare Earth Cryptates as a New Type of fluorescent Label
The limitations of existing chelates led to the search for new rare earth complexes. This analysis was based on the belief that the most important criteria for such a complex should not be based on a thermodynamic analysis of its behavior in water, but rather on its kinetic stability in biological media, allowing the formation of the complex in organic media. Once formed, the complex should have a very low dissociation rate in solution (26) .
This requirement was fulfilled
by rare earth cryptates (27,28), a finding that led to the initiation of a program to incorporate organic donor moieties that possessed the suitable absorption and emission levels for an efficient intramolecular energy transfer to the rare earth ion (29) (30) (31) (32) (33) . The main photophysical properties of the photoactive cryptate are also conserved, thus allowing the use of this tracer in immunoassays.
The behavior of this cryptate has been studied in biological media, and, more specifically, in high concen- acteristic of antigen-antibody complexes but not at greater distances. Unfortunately, many drawbacks arise from the interactions of the labels with sera, from nonspecific signals due to the fluorescence and diffusion properties of sera, and from donor fluorescence when the signal of the acceptor is measured. This explains the need for high serum dilution and thus the relatively low sensitivity of such homogeneous assays.
TBP(Eu3)
is very stable in serum but has a low quantum yield (<15%), which prevents it from being considered as a suitable donor in a sensitive homogeneous assay. Transfer efficiency (cIi) is thought to be related directly to the quantum yield of the donor (o).
Nonradiative Energy Transfer
According to the literature (50), k, the rate of energy transfer between two-point dipoles at a distance R, is given by the use of equations 1, 2, and 3, and, under certain conditions, the system allows an amplification of the donor signal (51-55). In fact, in a rare earth chelate, the real donor is the rare earth ion itself. Thus, the quantum yield to be used in the expression of R0 and k (equations 1, 2, and 3) is 4EU and not ct (R0 and k multiplied respectively by 1.2 and 3 in this demonstration). Moreover, when the fluorescence is measured at the emission wavelength of the acceptor, an amplification of the fluorescence is obtained when (IA(IT > EU (4A = quantum yield of the acceptor). Another particular property of rare earth ions is that the emission spectra are spread over more than 100 mu (Figure 3) . From a practical point of view, the rare earth ion fluorescence is measured at a single wavelength or through an interference filter centered on the most intense peak (-580 mu in this case); however, this measures only part of the emitted energy (<60%). In contrast, if the acceptor emission is a single peak, almost all of the emitted energy can be measured.
This allows an additional amplification, depending on the rare earth ion spectrum and the wavelength of the filters used.
Time-Resolved Detection of Acceptor Signal Theoretical and practical studies have shown that, in nonradiative energy transfer, the temporal component of the fluorescence signal emitted by the acceptor will present a contribution equal to that of the donor in the presence of energy transfer (52) . Given that, in this case, the donor is long-lived, the fluorescence emitted by the acceptor will also be long-lived (52, 53). Thus one can measure the amplified fluorescence emitted by the acceptor in the time-resolved mode. This mode of measurement allows one to make a clear distinction between the signal of the acceptor in the immune complex and that of the excess acceptor label in solution.
Choice of Acceptor
A good acceptor for this amplification method must fulfill a very stringent set of criteria for energy transfer Rare earth chelates have fluorescence spectra containing several peaks characteristic of the rare earth ion. The peaks, some of which are well separated from the acceptor emission, are spread over more than 100 nm (Figure 3) . It can therefore be seen that if one of the rare earth emission peaks in this assay is measured, it will be proportional to the concentration of the free donor (which is constant, as described above) and to the optical property of the medium at the excitation wavelength. As a result, the ratio of the fluorescence measurements on two wavelengths (one characteristic of the acceptor emission and the other of the donor emission) will depend solely on the immune complex concentration and thus on the antigen concentration (57) . A dedicated instrument has been constructed for this double wavelength detection (Figure 4 ).
Principles of the Assay
I used a prolactin assay as a model for the application of these 
Fig.4. Doublewavelengthprototype
The beamofa nitrogen laser (1) is focused on thewells of a microtiter plate (5) by theuseof a beamsplItter(3) and convenient optical lens (2) . ThelluorescenceemissionIs collected (collecting lens 4) and splitby a dlchrolc beam splitter (6) ontwophotomultlpilers (7, 8) the simultaneous detection of the reference signal at 620 ma and the specific amplified signal at 665 nm by time-resolved measurements.
For each standard or sample, the fluorescence ratio at 665 nm over that at 620 mn (arbitrary units) was computed and the standard curve drawn by plotting the standard 665/620 ratio vs their concentration. The detection limit, determined as the zero standard value +2 SD, is 0.3 g'L ( Figure 6 ), which compares very well with heterogeneous assays based on radioactive labels (58). (FIg.4) wIthA.,, 337 nm, delay 50 pa, gate 400 pa, and detection at 665 and 620 nm.AU, arbitrary unit jecting the serum and free APC background signals. Because the APC signal, amplified compared with that of the TBP(Eu31 in the immune complex, occurred in a spectral range with only insignificant TBP(Eu3) emission, highly sensitive assays could be performed.
Moreover, because the features of the system allow a real-time correction of the emitted signal for sample optical quality and avoids the separation and washing steps of heterogeneous assays, very low CVs were obtained (data not shown).
The features of the new label TBP(Eu3) cryptate and the donor/acceptor pairs allow use in other domains where time-resolved fluorescence is needed. The analysis regarding rare earth chelates and energy transfer could also be of help in the field of energy transfer, where rare earth chelates could be used as spectroscopic rulers.
